Doxycycline Hyclate
Pricing Report NDC 68308-710-10

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Doxycycline Hyclate (NDC 68308-710-10) is $2.25430 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 17, 2024.

As a provided by Mayne Pharma Commercial Llc, this medication is distributed in a 100 TABLET, DELAYED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.25430
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 17, 2024
Billable Units
100 EA
Estimated Package Price
$225.43
Data Status
As of May 15, 2024
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
68308-710-10
Description
100 TABLET, DELAYED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $2.25430 to $9.84825 per EA. Over this 10 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.2543 - $9.8483
Market Volatility
336.87% Variance
Latest Trend
58.02%
Date Unit Price Unit Source Method Rate
Apr 17, 2024 $2.25430 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 19, 2018 $5.37004 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 19, 2018 $5.37004 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 22, 2017 $8.82646 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 22, 2017 $8.82646 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Apr 22, 2015 $9.29698 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2015 $9.29698 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 18, 2015 $9.37793 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2015 $9.26474 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $9.53030 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 19, 2014 $9.53030 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Mar 19, 2014 $9.53030 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Feb 19, 2014 $9.84825 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 22, 2014 $9.58632 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 21, 2013 $9.45474 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 21, 2013 $9.45474 EAC/I - Chain or Independent PharmacyCode 4G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: June 17, 2026